• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Annals of Long Term Care

  • Follow us on

Search

  • Home
  • ARCHIVES
    • Issues
    • Supplements/Webcasts
  • About Us
    • Mission Statement
    • Editorial Description
    • Editorial Board
    • Publishing Staff
    • Our Partners
    • AGS Affiliations
    • Reprints/Permissions
  • SUBMIT
    • Author Guidelines
    • Copyright Transfer Form
    • Author Disclosure Form
    • Submit Now
  • CONTACT
  • ADVERTISING
    • Print Rate Card
    • Online Rate Card
    • Classified Rate Card
    • Sales Contacts
  • Supplements/Special Projects
  • Journal News
  • WEBCASTS
    • Facing Postherpetic Neuralgia in LTC
    • Treatment for Postherpetic Neuralgia Pain
    • Case Study—LTC Patient Suffering from PHN

Q & A With the Expert on: Congestive Heart Failure

  • Thu, 9/10/09 - 12:04pm
  • 0 Comments
  • 2068 reads

Q: How should a 78-year-old woman with congestive heart failure (CHF) after myocardial infarction be treated?

Case Presentation

A 78-year-old functionally independent woman has a 10-year history of hypertension and dyslipidemia. She developed CHF after an acute myocardial infarction 3 months ago. She has a nonproductive cough when lying down and New York Heart Association (NYHA) class III symptoms (dyspnea with less than ordinary activity). Her current medications include furosemide 40 mg daily, ramipril 10 mg twice daily, rosuvastatin 20 mg daily, diltiazem CD 240 mg dai



Read the full story >>

Q & A With the Expert on: Atrial Fibrillation

  • Thu, 7/9/09 - 3:48pm
  • 0 Comments
  • 1886 reads

Q: Should a 78-year-old woman with atrial fibrillation with hypertension, diabetes, prior heart failure, and prior stroke without contraindications to warfarin be treated with warfarin or aspirin? If warfarin, to what international normalized ratio?

Case Presentation

A 78-year-old functionally independent woman has had hypertension and diabetes mellitus for the past 1 year. Six months ago, she developed congestive heart failure (CHF) precipitated by an episode of paroxysmal atrial fibrillation (AF), with an average ventricular rate of 165 beats per minute, which resolved



Read the full story >>

LATEST NEWS

  • FDA Finally Approves Once-Weekly Type 2 Diabetes Treatment
    [Amylin] 1-31-12
  • FDA approves Voraxaze to treat patients with toxic methotrexate levels
    [FDA] 1-17-12
  • FDA approves first generic version of cholesterol-lowering drug Lipitor
    [FDA] 11-30-11
  • AHRQ Awards $34 Million To Expand Fight Against Healthcare-Associated Infections
    [AHRQ] 11-17-11
more »

Poll

Are nutritional supplements underutilized in long-term care?:

Classified/Recruitment Opportunities

  • Advertise Your Job Here
more »

ALTC Blogs

Getting the Most Out of Your Continuing Medical Education Classes

Neil Baum MD
2/8/12 | 0 Comments | 7 reads

February is American Heart Month

Alvin B Lin MD FAAFP
2/7/12 | 0 Comments | 26 reads

How to Create Collegiality in a Difference of Opinion: Part 2

Neil Baum MD
2/6/12 | 0 Comments | 35 reads
more »
banner banner banner banner banner
HMP Communications © 2012 HMP Communications
  • Home
  • About Us
  • Other Publications
  • Contact Us
  • Privacy Policy

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. © 2012 HMP Communications